This inventor holds 9 USPTO granted patents and 5 published patent applications and 7 EPO patents. Top assignees: Zhucheng Haotian Pharm Co., Ltd., Cocrystal Technology (Jiaxing) Co., Ltd., Shanghai Ri Xin Biotechnology Co., Ltd.. Active years: 2017-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Shandong, CN (2021)
- Shanghai, CN (2017 - 2024)
Company Filing History:
4 out of 4 
2 out of 2 
2 out of 3 Years Active: 2017-2026
Title: The Innovative Journey of Inventor Xuefeng Mei
Introduction:
Inventor Xuefeng Mei, hailing from Shanghai, China, has made remarkable strides in the field of pharmaceutical technology with a total of 7 patents to his name.
Latest Patents:
Among his latest patents is the groundbreaking invention involving crystalline polymorphs of benfotiamine. These unique polymorphs, labeled as forms A, B, C, D, and E, exhibit distinctive properties useful in treating various medical conditions such as Vitamin B1 deficiency and neurodegenerative diseases. Additionally, Mei's invention extends to the preparation processes and utilization of these polymorphs, solidifying his reputation as a pioneering innovator in the pharmaceutical sector.
Another notable patent by Mei revolves around the creation of the stevioside M crystal form. This crystal form boasts exceptional characteristics like high crystallinity, stability, and low hygroscopicity, making it a valuable addition to the realm of high-intensity sweeteners. The method of preparation outlined in this patent showcases Mei's commitment to simplicity, selectivity, and reproducibility in his inventive endeavors.
Career Highlights:
Xuefeng Mei has left a lasting impact through his tenure at companies like Zhucheng Haotian Pharmaceutical Co., Ltd. and Shanghai Ri Xin Biotechnology Co., Ltd., where he has undoubtedly played a pivotal role in driving innovation within the pharmaceutical and biotechnology sectors.
Collaborations:
Throughout his career, Mei has collaborated with esteemed colleagues such as Liping Zhu and Jianrong Wang, collectively contributing to the advancements in pharmaceutical technologies and solidifying his position as a visionary inventor in the industry.
Conclusion:
In conclusion, Xuefeng Mei's exceptional contributions to pharmaceutical innovation, as evidenced by his patents and collaborations, underscore his unwavering dedication to pioneering transformative solutions in the realm of medicinal advancements. His inventive spirit and drive for excellence continue to inspire and shape the landscape of pharmaceutical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile